Optimum Investment Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$384 Hold
36
﹤0.01% 601
2025
Q2
$348 Hold
36
﹤0.01% 602
2025
Q1
$536 Hold
36
﹤0.01% 623
2024
Q4
$537 Hold
36
﹤0.01% 600
2024
Q3
$689 Sell
36
-102
-74% -$2.11K ﹤0.01% 615
2024
Q2
$2.86K Hold
138
﹤0.01% 584
2024
Q1
$2.59K Sell
138
-30
-18% -$515 ﹤0.01% 592
2023
Q4
$2.42K Sell
168
-30
-15% -$408 ﹤0.01% 581
2023
Q3
$3.44K Sell
198
-56
-22% -$1.17K ﹤0.01% 629
2023
Q2
$5.29K Hold
254
﹤0.01% 607
2023
Q1
$5.97K Sell
254
-25
-9% -$671 ﹤0.01% 608
2022
Q4
$7.79K Sell
279
-80
-22% -$2.05K ﹤0.01% 591
2022
Q3
$8K Sell
359
-35
-9% -$1.06K ﹤0.01% 608
2022
Q2
$13K Hold
394
0.01% 572
2022
Q1
$14K Sell
394
-2
-0.5% -$68 0.01% 609
2021
Q4
$12K Sell
396
-311
-44% -$10.1K ﹤0.01% 661
2021
Q3
$23K Sell
707
-178
-20% -$5.7K 0.01% 583
2021
Q2
$27K Buy
+885
New +$29.1K 0.01% 618

Other funds holding OGN

Optimum Investment Advisors's OGN Position: Q3 2025 in Review

Optimum Investment Advisors held its Organon & Co (OGN) position steady in Q3 2025 at 36 shares worth $384. The position accounts for ﹤0.01% of the portfolio, ranked #601.

Optimum Investment Advisors first reported a position in OGN in Q2 2021 and has held it in 18 quarters since. The position peaked at $27K in Q2 2021. 670 funds tracked by Wall St. Rank hold OGN as of Q3 2025.

  • Optimum Investment Advisors held 36 shares of Organon & Co worth $384 as of Q3 2025.
  • Optimum Investment Advisors left its Organon & Co share count unchanged in Q3 2025.
  • Organon & Co made up ﹤0.01% of Optimum Investment Advisors's portfolio in Q3 2025, its #601 holding.
  • Optimum Investment Advisors first reported a position in Organon & Co in Q2 2021 and has held it in 18 quarters since.
  • Optimum Investment Advisors's Organon & Co position peaked at $27K in Q2 2021.
  • 670 funds tracked by Wall St. Rank held Organon & Co as of Q3 2025.

Based on Optimum Investment Advisors's 13F filing for Q3 2025, filed 21 Oct 2025.